The Barakat Pharmaceutical Group has signed investment contracts with 30 and domestic medical and healthcare companies in the healthcare industry.[15]So far in order to produce medicines, there are three contracts between pharmaceutical companies from Switzerland, the UK and Denmark for producing medicines.[16]The direct investment contract of € 70 million with a Danish pharmaceutical company in 2015[16][3][18] and a contract of $ 15 million with a Swiss company in 2016 were among the most important of these contracts.[19][20][21]